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Abstract 
 
Papillary tumors of the pineal region (PTPR) are rare brain tumors characterized by frequent 
local recurrences. Standardized treatment strategies are not yet defined.  We present the case 
of a three-year-old girl diagnosed with PTPR. Due to her young age, adjuvant radiotherapy 
was omitted after gross total tumor resection. Thirty-six months later, local tumor recurrence 
occurred. Considering the possible risks of secondary surgery, the recurrent tumor was 
proton-beam irradiated. Three months later, the tumor showed near-complete remission. 
Based on this experience and other pediatric case reports from the literature, local 
radiotherapy might be suggested also after complete tumor resection. 
 
 
 
Introduction  
 
Tumors of the pineal region account for about 3-4% of all brain tumors in childhood [1]. 
Papillary tumors of the pineal region (PTPR) represent a rare and histologically distinct 
subgroup of tumors originating in this area [2,3]. First described by Jouvet et al. in 2003 [3], 
PTPR have been included in the 2007 World Health Organization Classification of Tumors of 
the Nervous System as a separate tumor entity [4]. Among 70 PTPR reported to date, 
examples are recognized in both children and adults with ages ranging from 5-67 years (mean, 
34 years) [5]. PTPR has a distinctive epithelial character and shows both solid and papillary 
architecture [3,5,6]. Immunohistochemical analysis is crucial to distinguish PTPR from 
morphological similar pineal tumors, mainly papillary ependymoma and choroid plexus 
papilloma [7]. PTPR express strong immunoreactivity for CK18, S100, NCAM, NSE and 
vimentin. Due to the specific localization of this entity in the region of the posterior 
commissure and the distinctive immunohistochemical profile, PTPR is presumed to arise from 
the specialized ependyma of the subcommisural organ. Recent ultrastructural studies have 
demonstrated that PTPR has concomitant ependymal, neuroendocrine, and secretory features, 
lending further support to this hypothesis [8]. Despite advances in immunohistochemistry and 
cytogenetics, the biological behavior of PTPR is still not fully understood.  Thus, uniform 
therapeutic guidelines have not yet been established. Here, we describe a case of PTPR in a 
three-year old girl with 3.5 years of clinical and neuro-radiological follow up.  
 
Case report 
 
Clinical presentation 
A three-year-old girl presented to her pediatrician with a history of new-onset headaches 
accompanied by nausea, lasting for several hours a day. The neurological examination was 
normal and migraine was initially suspected. After symptoms persisted for two weeks, cranial 
magnetic resonance imaging (MRI) was performed. The MRI revealed a cerebral mass 
located in the pineal region measuring 2x2.8x3.5cm (Fig. 1A). The tumor displayed dorsal 
cystic structures and a ventral solid portion with inhomogeneous contrast agent enhancement 
leading to a compression of the tectum. The consecutive aqueductal stenosis resulted in 
occlusive hydrocephalus. A ventriculostomy of the third ventricle was performed to reduce 
intracranial pressure. Two weeks later, the patient underwent gross total tumor resection 
through a suboccipital supracerebellar approach. Postoperative imaging demonstrated 
complete resection. On postoperative clinical examination, the girl was found to have a 
vertical supranuclear gaze palsy, convergence deficit and mid-dilated pupils (Parinaud’s 
syndrome). This functional deficit led to gait instability, particularly when climbing stairs.  
Further treatment options were thoroughly discussed. Given the young age of the patient and 
macroscopically gross total tumor resection, the decision was made to omit adjuvant 
radiotherapy. The girl was followed at 3-month intervals by clinical examinations and cranial 
MRI. Control intervals were expanded to once every 6 months during the second 
postoperative year. The clinical course was uneventful, except for persistent vertical gaze 
palsy. Local tumor recurrence was detected on routine follow-up MRI after 3 years (Fig. 1B). 
The solid and partially cystic recurrent tumor was located within the third ventricle dorsal-
inferior of the interthalamic adhesion without disturbance of cerebral spinal fluid (CSF) 
circulation, approximately 1.8x0.7x1.3cm in size. At this time, the patient did not show any 
additional neurological symptoms. The possibility of a second surgery was rejected 
considering the potential risks of additional neurological damage. Subsequently, it was 
decided to treat the recurrent tumor with proton-beam radiation, with 54 Gy in fractions of 1.8 
Gy per session 5 days a week (total of 30 sessions). At first follow-up, 3 months after 
completion of therapy, the MRI demonstrated near-complete remission (Fig. 1C). 
 
Histological diagnosis 
Histopathological examination revealed a moderately cellular, epithelial tumor with solid and 
papillary growth patterns (Fig. 1D). Perivascular pseudorosette formation was a prominent 
feature; however, true rosettes could not be demonstrated. The cytoplasm of the neoplastic 
cells varied from clear to amphophilic. Areas of necrosis were present and mitotic activity 
was moderate (4-6/10HPF). Immunohistochemical analysis showed positive cytoplasmic 
staining for neuron specific enolase (NSE) and MAP2, while S100 protein was 
inhomogeneously expressed. Some tumor cells, mostly those forming papillary structures, 
displayed positivity for Pan-cytokeratin (CK). Glial fibrillary acidic protein (GFAP) 
immunolabeling was minimal and restricted to perivascular areas, particularly adjacent to 
blood vessels. Staining for other neuronal markers like N-Neu, Chromogranin A, 
Neurofilament 200, Neurofilament 70 and Synaptophysin was negative. The Ki67 
proliferation index was up to 10-15%. 
 
Discussion 
Grading criteria and therapeutic protocols for PTPR have not yet been established, because of 
the rarity and relatively new diagnosis in the 2007 World Health Organization Classification 
of Tumors of the Nervous System. Considering its frequent local recurrence, PTPR is thought 
to correspond at least to WHO grade II/III. To gain further insight into tumor characteristics, 
genetic analysis has been performed by comparative genomic hybridization and gene 
expression studies [9]. Losses on chromosome 10 and 22q and gains on chromosomes 4, 8, 9 
and 12 have been detected. Gene expression analysis has shown up-regulation of genes such 
as ZH4, RFX3, TTR mRNA and CGRP [7,10]. Clinical implication of these findings has not  
yet been elucidated. 
 
Since its original description by Jouvet et al. in 2003, about 70 cases have been reported in 
literature [5,11]. Among these patients, 10 were children under 16 years of age (Table 1) [5-
7,12,13]. Clinical manifestations include headache, diplopia, dizziness and vomiting [5,12-
14]. Spinal dissemination is rare at the time of diagnosis. A key feature of PTPR is their high 
risk for local recurrence. Four out of 6 pediatric patients suffered from local tumor recurrence, 
the others were lost to follow-up [6,12,13]. Poulgrin et al. investigated the 5-year and 10-year 
progression free survival of all reported cases to date, which has been estimated at 34.5% and 
8.6%, respectively [5]. Fèvre-Montange et al. performed univariate analysis to test the 
prognostic significance of clinical variables such as age, gender, tumor size, gross total tumor 
resection and adjuvant radiotherapy [6]. The only clinical factor that tended to be associated 
with overall survival and recurrence was the extent of resection [6].  
 
Standardization of treatment regimen is not yet determined due to the lack of reliable clinical 
and biological predictors and the small number of cases with careful follow-up. Maximal 
surgical tumor resection is suggested as the first line procedure. Radiotherapy and 
chemotherapy have been adopted as further treatment options yet [5]. Radiotherapy has been 
applied in about two thirds of all reported patients using different protocols and methods [5]. 
In the current report, radiotherapy was initially avoided because of the young age of the 
patient and total tumor resection. However, tumor relapse occurred 3 years after diagnosis, 
confirming the high risk of local recurrence in PTPR. With respect to the apparent high 
propensity of local recurrence, radiotherapy might be suggested as an additional therapeutic 
option, even in young patients with gross total tumor resection. Especially in young patients, 
proton-beam irradiation is superior in terms of minimizing the risk of damage to adjacent 
normal tissue. 
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Figure 1. A) Sagittal preoperative T2-weighted MRI showing a cerebral mass with cystic 
portions located in the pineal region. B) Local tumor recurrence 36 months after complete 
resection. C) Axial T2-weighted MRI obtained after proton-beam-therapy. A small residual 
tumor is seen only on axial slices (arrow). D) Histopathological features of PTPR 
demonstrating solid and papillary growth pattern with perivascular pseudorosette formation. 
 
Table 1. Pediatric patients with PTPR. Treatment modalities and outcome. 
 
Case 
[Reference
] 
Age 
(years) 
Gende
r 
Tumor 
size (mm)
Operatio
n 
Adjuvant 
therapy 
Follow-
up 
(months) 
Recurrenc
e 
(months) 
1 [15] 1 3/12 M 10 IR CT, RT 15  NA 
2 [7] 5 F 28 CR CT, RT 24  21   
3 [8] 11 F NA NA NA NA NA 
4 [7] 11 F 30 IR, CR CT, RT 79  72   
5 [7] 13 M NA CR RT 5   NA 
6 [14] 13 M 31 CR RT 15   NA 
7 [7] 14 M NA CR NA NA NA 
8 [7] 14 M 50 CR CT, RT 102    44, 53, 88   
9 [8] 14 M NA NA NA NA NA 
10 [8] 14 M NA NA NA NA NA 
NA = not available, M = male, F = Female, CR = complete resection, IR = incomplete 
resection, CT = Chemotherapy, RT = Radiotherapy 
 
 
 
 
 
